Mascoma
Latest round
- Series C
Last raised
- May 2008
Total raised
- $95M
Investors
- 8
About Mascoma
Founded in 2005 and headquartered in Lebanon, US, Mascoma develops innovative microbial products primarily for biofuel production. In November 2014, the company was acquired by Lallemand.Mascoma specializes in the development of innovative microbial products aimed primarily at enhancing industrial biotechnology applications. The company’s core offerings include the TransFerm family, which optimizes bioethanol production from corn by utilizing a unique strain of Saccharomyces cerevisiae that expresses glucoamylase, thereby improving yield and reducing glycerol byproducts. Additionally, the FiberFerm and C5 Fuel products provide solutions for cellulosic ethanol production by converting 5-carbon sugars, enhancing efficiency and reducing waste in the process. Other notable products include SucraMax, which contributes to improved bioethanol yields in sugar-cane fermentation, and Softzyme, an enzyme designed for the baking industry that ensures consistent bread quality over its shelf life.Mascoma’s revenue generation model is primarily B2B, with a focus on partnerships and direct sales to clients in the food and beverage and biofuel industries. The company engages in transactions that typically involve bulk sales of its microbial products to manufacturers who integrate these solutions into their production processes. For instance, a beverage manufacturer might procure Softzyme in large quantities to enhance the quality of its baked goods, while a bioethanol facility may enter into a long-term agreement for the TransFerm products to optimize their operations. Each product is tailored to meet specific industry demands, allowing customers to benefit from improved efficiency and sustainability in production.Looking ahead, Mascoma aims to expand its product line, including new microbial solutions, although specific release dates have not been disclosed. The company is also targeting expansion into additional markets, with a focus on increasing its presence in Europe and Asia by 2025.08 mn in Venture Debt, will be utilized to support these initiatives and enhance their research and development efforts.
Who invested in Mascoma
8 investors across 3 rounds
See all investors in Mascoma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mascoma
Who invested in Mascoma?
Mascoma has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mascoma raised?
Mascoma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Mascoma last raise money?
Mascoma's most recent round on record is a Series C, in May 2008.
What does Mascoma do?
Founded in 2005 and headquartered in Lebanon, US, Mascoma develops innovative microbial products primarily for biofuel production.
Where is Mascoma headquartered?
Mascoma is headquartered in Lebanon, US.
Which VCs invest in companies like Mascoma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back renewable energy companies at Mascoma's stage. Their profiles are linked below.
VCs backing renewable energy startups at Series C
Raising like Mascoma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.